Research Article
Wnt/β-Catenin, Carbohydrate Metabolism, and PI3K-Akt Signaling Pathway-Related Genes as Potential Cancer Predictors
Table 4
Performances of pathway-related genes and DEGs in test sets.
| Genes | Test set | COAD (%) (normal/tumor = 9/123) | BRCA (%) (normal/tumor = 35/332) | STAD (%) (normal/tumor = 11/112) | PRAD (%) (normal/tumor = 16/149) | SVM | RF | DT | KNN | SVM | RF | DT | KNN | SVM | RF | DT | KNN | SVM | RF | DT | KNN |
| Wnt | 100.00 | 99.90 | 94.03 | 99.86 | 99.95 | 97.64 | 88.79 | 100.00 | 99.26 | 98.70 | 79.13 | 99.75 | 95.76 | 95.55 | 76.65 | 95.26 | Ca-Me | 100.00 | 100.00 | 99.18 | 100.00 | 99.96 | 99.50 | 88.42 | 100.00 | 99.10 | 97.88 | 75.04 | 97.44 | 94.75 | 96.95 | 79.67 | 95.11 | PI3K | 100.00 | 100.00 | 100.00 | 99.95 | 99.92 | 99.43 | 98.41 | 99.66 | 99.35 | 98.53 | 84.57 | 97.44 | 96.56 | 91.61 | 86.01 | 95.91 | TLR | 100.00 | 97.01 | 88.48 | 100.00 | 99.87 | 99.35 | 90.17 | 99.44 | 98.62 | 98.01 | 86.36 | 95.37 | 93.20 | 92.05 | 78.56 | 86.79 | TH | 100.00 | 99.72 | 99.18 | 99.86 | 99.93 | 98.86 | 83.38 | 99.57 | 99.43 | 98.45 | 80.92 | 97.93 | 96.60 | 89.53 | 64.91 | 91.42 | RPSC | 100.00 | 99.86 | 94.03 | 99.95 | 99.93 | 99.93 | 94.13 | 99.84 | 99.26 | 98.25 | 83.68 | 98.74 | 94.67 | 93.12 | 79.88 | 95.05 | DEGs | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 99.96 | 99.03 | 99.29 | 99.35 | 99.10 | 88.67 | 96.02 | 93.37 | 92.76 | 85.48 | 91.23 |
|
|
Note. COAD, colorectal cancer; BRCA, breast cancer; STAD, gastric cancer; PRAD, prostate cancer; Wnt, Wnt signaling pathway; Ca-Me, carbohydrate metabolism signaling pathway; PI3K, PI3K-Akt signaling pathway; TLR, toll-like receptor signaling pathway; TH, thyroid hormone signaling pathway; RPSC, signaling pathways regulating pluripotency of stem cells.
|